Lu XF - Search Results

1

Prognostic values of the inhibitor of DNA‑binding family members in breast cancer.

Zhou XL, Zeng D, Ye YH, Sun SM, Lu XF, Liang WQ, Chen CF, Lin HY. Zhou XL, et al. Among authors: lu xf. Oncol Rep. 2018 Oct;40(4):1897-1906. doi: 10.3892/or.2018.6589. Epub 2018 Jul 23. Oncol Rep. 2018. PMID: 30066902 Free PMC article.

2

CCR10 activation stimulates the invasion and migration of breast cancer cells through the ERK1/2/MMP-7 signaling pathway.

Lin HY, Sun SM, Lu XF, Chen PY, Chen CF, Liang WQ, Peng CY. Lin HY, et al. Among authors: lu xf. Int Immunopharmacol. 2017 Oct;51:124-130. doi: 10.1016/j.intimp.2017.07.018. Epub 2017 Aug 19. Int Immunopharmacol. 2017. PMID: 28830025

3

FoxM1 is a promising candidate target in the treatment of breast cancer.

Lu XF, Zeng D, Liang WQ, Chen CF, Sun SM, Lin HY. Lu XF, et al. Oncotarget. 2017 Dec 12;9(1):842-852. doi: 10.18632/oncotarget.23182. eCollection 2018 Jan 2. Oncotarget. 2017. PMID: 29416660 Free PMC article.

4

Predictive Value of Preoperative Multidetector-Row Computed Tomography for Axillary Lymph Nodes Metastasis in Patients With Breast Cancer.

Chen CF, Zhang YL, Cai ZL, Sun SM, Lu XF, Lin HY, Liang WQ, Yuan MH, Zeng D. Chen CF, et al. Among authors: lu xf. Front Oncol. 2019 Jan 8;8:666. doi: 10.3389/fonc.2018.00666. eCollection 2018. Front Oncol. 2019. PMID: 30671386 Free PMC article.

5

Long noncoding RNA H19 is a critical oncogenic driver and contributes to epithelial-mesenchymal transition in papillary thyroid carcinoma.

Liang WQ, Zeng D, Chen CF, Sun SM, Lu XF, Peng CY, Lin HY. Liang WQ, et al. Among authors: lu xf. Cancer Manag Res. 2019 Mar 6;11:2059-2072. doi: 10.2147/CMAR.S195906. eCollection 2019. Cancer Manag Res. 2019. PMID: 30881130 Free PMC article.

6

Trastuzumab resistance in HER2-positive breast cancer: Mechanisms, emerging biomarkers and targeting agents.

Wang ZH, Zheng ZQ, Jia SC, Liu SN, Xiao XF, Chen GY, Liang WQ, Lu XF. Wang ZH, et al. Among authors: lu xf. Front Oncol. 2022 Oct 6;12:1006429. doi: 10.3389/fonc.2022.1006429. eCollection 2022. Front Oncol. 2022. PMID: 36276152 Free PMC article. Review.

7

RNA-binding proteins in breast cancer: Biological implications and therapeutic opportunities.

Wang S, Sun H, Chen G, Wu C, Sun B, Lin J, Lin D, Zeng D, Lin B, Huang G, Lu X, Lin H, Liang Y. Wang S, et al. Crit Rev Oncol Hematol. 2024 Mar;195:104271. doi: 10.1016/j.critrevonc.2024.104271. Epub 2024 Jan 23. Crit Rev Oncol Hematol. 2024. PMID: 38272151 Free article. Review.

8

Sp1 and AP-1 regulate expression of the human gene VIL2 in esophageal carcinoma cells.

Gao SY, Li EM, Cui L, Lu XF, Meng LY, Yuan HM, Xie JJ, Du ZP, Pang JX, Xu LY. Gao SY, et al. Among authors: lu xf. J Biol Chem. 2009 Mar 20;284(12):7995-8004. doi: 10.1074/jbc.M809734200. Epub 2009 Jan 21. J Biol Chem. 2009. PMID: 19164283 Free PMC article.

9

Phosphorylation of fascin decreases the risk of poor survival in patients with esophageal squamous cell carcinoma.

Zhao Q, Shen JH, Shen ZY, Wu ZY, Xu XE, Xie JJ, Wu JY, Huang Q, Lu XF, Li EM, Xu LY. Zhao Q, et al. Among authors: lu xf. J Histochem Cytochem. 2010 Nov;58(11):979-88. doi: 10.1369/jhc.2010.955765. Epub 2010 Aug 16. J Histochem Cytochem. 2010. PMID: 20713986 Free PMC article.

10

Specificity protein 1 regulates fascin expression in esophageal squamous cell carcinoma as the result of the epidermal growth factor/extracellular signal-regulated kinase signaling pathway activation.

Lu XF, Li EM, Du ZP, Xie JJ, Guo ZY, Gao SY, Liao LD, Shen ZY, Xie D, Xu LY. Lu XF, et al. Cell Mol Life Sci. 2010 Oct;67(19):3313-29. doi: 10.1007/s00018-010-0382-y. Epub 2010 May 26. Cell Mol Life Sci. 2010. PMID: 20502940 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

326 results

Search Page

Filters